A Korea-Japan multicenter joint project on Postoperative Adjuvant treatment for Ampulla of Vater cancer

A Korea-Japan multicenter joint project on Postoperative Adjuvant treatment for Ampulla of Vater cancer - A Korea-Japan multicenter joint project on Postoperative Adjuvant treatment for Ampulla of Vater cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037916

Enrollment

1090

Registered

2019-09-05

Start date

2019-04-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ampulla of Vater Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent operation for ampulla of vater carcinoma and diagnosis confirmed by histopathology between 2002. 1 and 2015. 12 Patients who underwent completed resection of tumor (included only R0 resection)

Exclusion criteria

Exclusion criteria: Patients without available data in the case report form (CRF) Patients with combined cancer 30-day mortality case associated with operative complication Patients with neoadjuvant treatment Patients with R1/R2 resection of tumor

Design outcomes

Primary

Measure	Time frame
3 year & 5 year overall survival 3 year & 5 year disease free survival	—

Secondary

Measure	Time frame
Recurrence patterns according to postoperative adjuvant treatment.	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactYasuhiro Yabushita

Yokohama City University Department of Gastroenterological Surgery

yabu23@yokohama-cu.ac.jp0457872650

Outcome results